Liver-test abnormalities in sarcoidosis

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 1, 2012, Pages 17-24

  Cremers, Johanna ^a   Drent, Marjolein ^a   Driessen, Ann ^a   Nieman, Fred ^a   Wijnen, Petal ^a   Baughman, Robert ^b   Koek, Ger ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Hepatic sarcoidosis; Histological abnormalities; Liver biopsy; Liver tests

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ABNORMAL LABORATORY RESULT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOPSY; FEMALE; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS;

EID: 82555169566     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834c7b71     Document Type: Article

References (36)

1. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007; 28:36-52. (Pubitemid 46364271)
3. Mueller S, Boehme MW, Hofmann WJ, Stremmel W. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol 2000; 35:1003-1008.
4. Kennedy PT, Zakaria N, Modawi SB, Papadopoulou AM, Murray-Lyon I, du Bois RM, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006; 18:721-726.
5. Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008; 103: 3184-3192.quiz 3193.
6. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr., Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889. (Pubitemid 33152325)
7. Ayyala US, Padilla ML. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol 2006; 9:475-483. (Pubitemid 44803669)
8. Judson MA. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med 2002; 23:529-541. (Pubitemid 36026366)
9. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001; 32 (Suppl):56s-68s. (Pubitemid 34755186)
10. Maddrey WC, Johns CJ, Boitnott JK, Iber FL. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore) 1970; 49:375-395.
11. Hercules HD, Bethlem NM. Value of liver biopsy in sarcoidosis. Arch Pathol Lab Med 1984; 108:831-834. (Pubitemid 14012833)
12. Klatskin G, Yesner R. Hepatic manifestations of sarcoidosis and other granulomatous diseases; a study based on histological examination of tissue obtained by needle biopsy of the liver. Yale J Biol Med 1950; 23:207-248.
13. Valla DC, Benhamou JP. Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis 2000; 4:269-285, ix-x.
14. Devaney K, Goodman ZD, Epstein MS, Zimmerman HJ, Ishak KG. Hepatic sarcoidosis. clinicopathologic features in 100 patients. Am J Surg Pathol 1993; 17:1272-1280.
15. Bilir M, Mert A, Ozaras R, Yanardag H, Karayel T, Senturk H, et al. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol 2000; 31:337-338.
16. Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:73-76. (Pubitemid 27170558)
17. Kahi CJ, Saxena R, Temkit M, Canlas K, Roberts S, Knox K, et al. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23:117-123. (Pubitemid 47471830)
18. Israel HL, Margolis ML, Rose LJ. Hepatic granulomatosis and sarcoidosis. Further observations. Dig Dis Sci 1984; 29:353-356. (Pubitemid 14131559)
19. Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis. Acta Med Scand 1977; 202:289-293. (Pubitemid 8196523)
20. Zimmerman HJ. The clinical importance of hepatic involvement in sarcoidosis. Stanford Med Bull 1953; 11:173-178.
21. Ishak KG. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 1998; 73:467-472. (Pubitemid 28231989)
22. Adler M, Burroughs A, Beynon H. Gastrointestinal sarcoidosis. A review. Sarcoidosis Vasc Diffuse Lung Dis 2007; 24:3-11. (Pubitemid 350177767)
23. Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol 2004; 19:732-737. (Pubitemid 38981392)
24. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 2006; 5:251-256. (Pubitemid 44904538)
25. Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004; 24:87-104. (Pubitemid 38134596)
26. Lebacq EG, Heller F. LP-X test in sarcoidosis patients with liver involvement: comparison with other liver function tests. Ann N Y Acad Sci 1976; 278:439-444.
27. Wijnen PA, Nelemans PJ, Verschakelen JA, Bekers O, Voorter CE, Drent M. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue Antigens 2010; 75:262-268.
28. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-1520. (Pubitemid 24166476)
29. Kleiner DEBE, Natta van M, Behling C, Contos MJ, Cummings OW, Ferrell LD, et al. For the nonalcoholic steatohepatitis clinical research network. design and validation of a histological scoring system for non alcoholic fatty liver disease. Hepatology 2005;1313-1321. (Pubitemid 40770284)
30. Baughman RP, Koehler A, Bejarano PA, Lower EE,Weber FL Jr. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 2003; 163:615-620. (Pubitemid 36314350)
31. Al Knawy B, Shiffman M. Percutaneous liver biopsy in clinical practice. Liver Int 2007; 27:1166-1173. (Pubitemid 47543144)
32. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14:543-548. (Pubitemid 30447225)
33. Adams TJL. Percutaneous liver biopsy. Clin Perspectives Gastroenterol 2002; 2:117-121.
34. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008; 14: 3396-3402.
35. Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, et al. Characterization of focal liver lesions with sonovue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15:3748-3756.
36. Tranquart F, Bleuzen A, Kissel A. Value of combined conventional and contrast enhanced sonography in the evaluation of hepatic disorders. J Radiol 2004; 85:755-762. (Pubitemid 38902260)